Sugi Predict

Sugi Predict / Compounds / SCHEMBL1371183

SCHEMBL1371183

SCHEMBL1371183

CCOC(=O)n1nc(NC(=O)c2c(F)cccc2[N+](=O)[O-])c2c1C(C)(C)N(S(=O)(=O)c1cc(F)cc(F)c1)C2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 1/20 0.34
▸ ALDH1A1 P00352 7/20 0.33
▸ LMNA P02545 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ POLB P06746 2/20 0.33
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ FKBP1A P62942 1/20 0.32
▸ MAPT P10636 5/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1372432 0.88 IGF1R (0.35) IGF1RALDH1A1LMNAKMT2APOLB
SCHEMBL1885047 0.83 IGF1R (0.39) IGF1RALDH1A1LMNAGAAMEN1
SCHEMBL1374649 0.83 IGF1R (0.40) IGF1RALDH1A1LMNAKMT2AMAPT
SCHEMBL4281921 0.82 IGF1R (0.51) IGF1RALDH1A1LMNAGAAMEN1
SCHEMBL4287464 0.81 KMT2A (0.34) ALDH1A1LMNAGAAGLAMEN1
SCHEMBL4427637 0.80 KMT2A (0.36) ALDH1A1LMNAGAAGLAMEN1
Hydrochloric Acid SCHEMBL4427627 0.80 KMT2A (0.36) ALDH1A1LMNAGAAGLAMEN1
SCHEMBL4281805 0.78 IGF1R (0.54) IGF1RALDH1A1LMNAMEN1KMT2A
SCHEMBL1373849 0.77 ALDH1A1 (0.40) ALDH1A1LMNAGAAGLAMEN1
SCHEMBL1370894 0.74 MAPT (0.38) IGF1RALDH1A1LMNAGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461193-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-06-11 — — US disclosed
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.I. (IT) 2011-11-24 — — US disclosed
US-7968583-B2 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-06-28 — — US disclosed
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163503-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 IGF1R 737/4885ALDH1A1 2548/4885LMNA 3860/4885
US-20110288088-A1 SUBSTITUTED PYRROLO-PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K5, MAP3K19, MAP3K3 IGF1R 737/4885ALDH1A1 2548/4885LMNA 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.